Lv4
444 积分 2023-11-15 加入
CycleDesigner: Leveraging CycRFdiffusion and HighFold to Design Cyclic Peptide Binders for Specific Targets
1天前
已完结
Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies
1天前
已完结
HighPlay: Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction
1天前
已完结
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
1个月前
已完结
An update on the role of miR-124 in the pathogenesis of human disorders
1个月前
已完结
Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis
1个月前
已完结
P025 Obefazimod and its active metabolites ABX-464-N-Glu act by stabilizing protein-protein interaction among key RNA biogenesis partners, CBC and ARS2
1个月前
已完结
Accelerated In Silico Discovery of SGR-1505: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies
2个月前
已完结
RGN6024 is a brain-penetrant, small molecule tubulin destabilizer for the treatment of glioblastoma
2个月前
已完结
MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies
2个月前
已完结
皖公网安备34019202002308
